Header Logo

Connection

SAPNA PRADYUMAN PATEL to Paclitaxel

Back to Details
This is a "connection" page, showing publications SAPNA PRADYUMAN PATEL has written about Paclitaxel.
SAPNA PRADYUMAN PATEL
Connection Strength
0.094
Paclitaxel
  1. Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies. Cancer. 2019 02 01; 125(3):463-472.
    View in: PubMed
    Score: 0.094
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.